1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with AIDS Dementia Complex in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayette, P; Dash, PK; Dong, CZ; Dou, H; Eggert, D; Gelbard, HA; Gendelman, HE; Gorantla, S; Heymans, F; Poluektova, L; Serradji, N | 1 |
| Bellizzi, MJ; Gelbard, HA; Lu, SM; Masliah, E | 1 |
| Dreyer, EB; Lipton, SA; Yeh, M | 1 |
| Choi, YB; Dzenko, KA; Gelbard, HA; Genis, P; Jett, M; Nottet, HS; Swindells, S; Wang, L; White, R; Zhang, D | 1 |
| Basile, AS; Kustova, Y; Markey, SP; Morse, HC; Nishida, K; Sei, Y; Skolnick, P | 1 |
| González-Scarano, F; Kolson, D; Westmoreland, SV | 1 |
| Bitler, CM; Pulliam, L; Stubblebine, M; Zhou, M | 1 |
| Gelbard, HA | 1 |
| Gearing, A; Gendelman, HE; Limoges, J; Persidsky, Y; Rasmussen, J; Zheng, J | 1 |
| Brew, BJ; Guillemin, GJ; Kerr, S; Nath, A; Pemberton, L; Smith, DG; Smythe, GA | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and AIDS Dementia Complex
| Article | Year |
|---|---|
Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide.
Topics: AIDS Dementia Complex; Arachidonic Acid; Cytokines; HIV Envelope Protein gp120; HIV Infections; Humans; Macrophages; Neurons; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Quinolinic Acid; Receptors, N-Methyl-D-Aspartate | 1994 |
9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and AIDS Dementia Complex
| Article | Year |
|---|---|
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.
Topics: AIDS Dementia Complex; Animals; Anti-Inflammatory Agents; Brain; Cell Death; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Focal Adhesion Kinase 2; Giant Cells; Gliosis; Humans; Immunologic Factors; Inflammation Mediators; Male; Mice; Mice, SCID; Microglia; Monocytes; NF-kappa B; Piperazines; Platelet Activating Factor | 2009 |
Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.
Topics: AIDS Dementia Complex; Animals; Calcium; Caspases; Dendritic Spines; Electric Stimulation; Hippocampus; Humans; Long-Term Potentiation; Male; Neurons; Organ Culture Techniques; Perfusion; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 2005 |
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Animals; Astrocytes; Cell Survival; Cells, Cultured; Child; Child, Preschool; Fetus; HIV-1; Humans; Infant; Middle Aged; Monocytes; Neurons; Platelet Activating Factor; Rats | 1994 |
Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediated.
Topics: AIDS Dementia Complex; Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Platelet Activating Factor; Receptors, N-Methyl-D-Aspartate | 1996 |
Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia.
Topics: AIDS Dementia Complex; Astrocytes; Cell Differentiation; HIV Envelope Protein gp120; HIV-1; Humans; Interferon-gamma; Interleukin-1; Microglia; Neurons; Neurotoxins; Platelet Activating Factor; Teratocarcinoma; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor.
Topics: AIDS Dementia Complex; Apoptosis; Astrocytes; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Brain; Cell Aggregation; Cells, Cultured; DNA Fragmentation; Gene Expression Regulation; Humans; Necrosis; Neurons; Oligodendroglia; Platelet Activating Factor; Protein Isoforms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Transfection; Tumor Necrosis Factor-alpha | 1998 |
Neuroprotective strategies for HIV-1-associated neurologic disease.
Topics: AIDS Dementia Complex; Apoptosis; HIV-1; Humans; Macrophages; Microglia; Neuroprotective Agents; Platelet Activating Factor; Receptors, AMPA; Tumor Necrosis Factor-alpha | 1999 |
Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis.
Topics: AIDS Dementia Complex; Animals; Benzyl Compounds; Cell Survival; Dexamethasone; Disease Models, Animal; Drug Combinations; Gliosis; HIV-1; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; Leucine; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, SCID; Microglia; Neurons; Pentoxifylline; Platelet Activating Factor; Protease Inhibitors; Succinates; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2001 |
Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.
Topics: AIDS Dementia Complex; Enzyme Induction; Gene Products, nef; Gene Products, tat; HIV Envelope Protein gp41; Humans; Interferon-gamma; Interleukin-1; Interleukin-6; Macrophages; nef Gene Products, Human Immunodeficiency Virus; Platelet Activating Factor; Quinolinic Acid; tat Gene Products, Human Immunodeficiency Virus; Transforming Growth Factor beta; Transforming Growth Factor beta2; Tryptophan Oxygenase | 2001 |